[2-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-1-(2-bromophenyl)ethyl]carbamic acid
C15H13BrIN5O2 — CID 175411613
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-1-(2-bromophenyl)ethyl]carbamic acid
[2-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-1-(2-bromophenyl)ethyl]carbamic acid (PubChem CID 175411613) has the molecular formula C15H13BrIN5O2 and a molecular weight of 502.11 g/mol. Its IUPAC name is [2-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-1-(2-bromophenyl)ethyl]carbamic acid.
Molecular Properties
| Compound Name | [2-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-1-(2-bromophenyl)ethyl]carbamic acid |
|---|---|
| PubChem CID | 175411613 |
| Molecular Formula | C15H13BrIN5O2 |
| Molecular Weight | 502.11 g/mol |
| Exact Mass | 500.93 |
| IUPAC Name | [2-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-1-(2-bromophenyl)ethyl]carbamic acid |
| SMILES | Nc1ncnc2c1c(I)cn2CC(NC(=O)O)c1ccccc1Br |
| InChI | InChI=1S/C15H13BrIN5O2/c16-9-4-2-1-3-8(9)11(21-15(23)24)6-22-5-10(17)12-13(18)19-7-20-14(12)22/h1-5,7,11,21H,6H2,(H,23,24)(H2,18,19,20) |
| InChIKey | YCLINSMRXARWFY-UHFFFAOYSA-N |
| XLogP | 3.39 |
| TPSA | 106.06 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.11 |
| LogP ≤ 5 | 3.39 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175411613 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.